SignatureFD’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52 Hold
23
﹤0.01% 3458
2026
Q1
$66 Hold
23
﹤0.01% 3405
2025
Q4
$74 Hold
23
﹤0.01% 3331
2025
Q3
$55 Hold
23
﹤0.01% 3333
2025
Q2
$112 Hold
23
﹤0.01% 3202
2025
Q1
$34 Hold
23
﹤0.01% 3291
2024
Q4
$44 Hold
23
﹤0.01% 3265
2024
Q3
$74 Hold
23
﹤0.01% 3195
2024
Q2
$163 Hold
23
﹤0.01% 3060
2024
Q1
$422 Hold
23
﹤0.01% 3045
2023
Q4
$247 Sell
23
-1
-4% -$12 ﹤0.01% 3042
2023
Q3
$468 Hold
24
﹤0.01% 3031
2023
Q2
$1.81K Hold
24
﹤0.01% 2838
2023
Q1
$2.24K Hold
24
﹤0.01% 2771
2022
Q4
$2.3K Sell
24
-8
-25% -$1.16K ﹤0.01% 2762
2022
Q3
$8K Buy
32
+8
+33% +$2.32K ﹤0.01% 2208
2022
Q2
$4K Hold
24
﹤0.01% 2551
2022
Q1
$2K Buy
24
+1
+4% +$128 ﹤0.01% 2862
2021
Q4
$4K Sell
23
-113
-83% -$24.8K ﹤0.01% 2516
2021
Q3
$37K Buy
136
+54
+66% +$16.5K ﹤0.01% 1463
2021
Q2
$33K Hold
82
﹤0.01% 1492
2021
Q1
$44K Sell
82
-2
-2% -$1.25K ﹤0.01% 1229
2020
Q4
$32K Buy
84
+61
+265% +$24.3K ﹤0.01% 1277
2020
Q3
$9K Sell
23
-3
-12% -$1.32K ﹤0.01% 1689
2020
Q2
$13K Sell
26
-6
-19% -$2.67K ﹤0.01% 1480
2020
Q1
$12K Buy
32
+9
+39% +$4.66K ﹤0.01% 1417
2019
Q4
$17K Hold
23
﹤0.01% 1333
2019
Q3
$15K Hold
23
﹤0.01% 1322
2019
Q2
$20K Hold
23
﹤0.01% 1205
2019
Q1
$13K Hold
23
﹤0.01% 1331
2018
Q4
$7K Hold
23
﹤0.01% 1467
2018
Q3
$11K Hold
23
﹤0.01% 1368
2018
Q2
$11K Buy
+23
New +$14.6K ﹤0.01% 1372
2016
Q4
Sell
-10
Closed -$8K 1101
2016
Q3
$8K Buy
+10
New +$8.04K ﹤0.01% 1103

Other funds holding TCRT

SignatureFD's TCRT Position: Q2 2026 in Review

SignatureFD held its Alaunos Therapeutics (TCRT) position steady in Q2 2026 at 23 shares worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #3458.

SignatureFD first reported a position in TCRT in Q3 2016 and has held it in 34 quarters since. The position peaked at $44K in Q1 2021. 7 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.

  • SignatureFD held 23 shares of Alaunos Therapeutics worth $52 as of Q2 2026.
  • SignatureFD left its Alaunos Therapeutics share count unchanged in Q2 2026.
  • Alaunos Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3458 holding.
  • SignatureFD first reported a position in Alaunos Therapeutics in Q3 2016 and has held it in 34 quarters since.
  • SignatureFD's Alaunos Therapeutics position peaked at $44K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.